Access Pharmaceuticals Announces New Data on Angiolix(R)
DALLAS, April 17 /PRNewswire/ --
- New Preclinical Data Suggests Potent Anti-Tumor Activity
ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced results from preclinical studies ongoing…